ArticleFrontiers in medicine2025
Implementation of a quality management system for decentralized manufacturing of cell and gene therapy products - technical and regulatory considerations.
Heiko von der Leyen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it